What is the purpose of this trial?
The objective in this study is to determine if MRI-identified progression can decrease frequency or need for repeated prostate biopsy in men on active surveillance (AS).
Our hypothesis is that MRI alone is adequate to detect progression of prostate cancer in men on active surveillance (AS) after a MRI-US fusion prostate biopsy.
Ages: 30 - 80 years
Yale University School of Medicine
Start Date: 06/11/2015
End Date: 01/23/2020
Last Updated: 02/22/2018
Study HIC#: 1501015246